NAD + in aging, metabolism, and neurodegeneration
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Nicotinamide adenine dinucleotide (NAD + ) is a coenzyme found in all living cells. It serves both as a critical coenzyme for enzymes that fuel reduction-oxidation reactions, carrying electrons from one reaction to another, and as a cosubstrate for other enzymes such as the sirtuins and poly(adenosine diphosphate–ribose) polymerases. Cellular NAD + concentrations change during aging, and modulation of NAD + usage or production can prolong both health span and life span. Here we review factors that regulate NAD + and discuss how supplementation with NAD + precursors may represent a new therapeutic opportunity for aging and its associated disorders, particularly neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, the total NAD+ + NADH pool was smaller in the apoE4 cells, suggesting that apoE4 impairs NAD+ synthetic capacity [68].”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [68]
In the citing paper
“Nicotinamide phosphoribosyl transferase (NAMPT) catalyzes the rate limiting step in the NAD salvage pathway from nicotinamide (NAM) (Garten et al., 2015; Verdin, 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Verdin, 2015
In the citing paper
“Persistently activated PARP1, however, consumes large amounts of NAD+, an essential coenzyme of sirtuins (SIRTs) (69).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [69]
In the citing paper
“restoration of NAD levels with the NAD precursor vitamins nicotinamide riboside (NR), nicotinamide (NAM) and nicotinic acid (NA), in addition to the biosynthetic NAD precursor nicotinamide mononucleotide (NMN), appears to mitigate several age-associated diseases2-4.”
From Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages (2020) · cites this paper as [4]
In the citing paper
“The NAD+ salvage pathway starts from the recycling of nicotinamide (NAM) to nicotinamide mononucleotide (NMN) by intracellular nicotinamide phosphoribosyltransferase (iNAMPT), followed by the conversion of NMN into NAD+ via the NMNATs (Bogan and Brenner, 2008; Verdin, 2015).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Verdin, 2015
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats
Braidy, N., Guillemin, G. J., Mansour, H., Chan-Ling, T., Poljak, A., & Grant, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019194 · Cited by 594
RetractedLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Cited by
Items 401–500 of 1,000
Moore, A. M., Zhou, L., Cui, J., Li, L., Wu, N., Yu, A. C., Poddar, S., Liang, K., Abt, E. R., Kim, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012469118 · Cited by 42
“To test this hypothesis, we profiled the mRNA levels of all reported NAD(H)consuming enzymes, including 16 PARP family members, 7 SIRT family members, and CD38, in two PDAC cell lines (Panc 03.27 and SUIT2) with and without IFNβ supplementation (Fig.”
BackgroundInfluentialHiggins, C. B., Mayer, A. L., Zhang, Y., Franczyk, M. P., Ballentine, S. J., Yoshino, J., & DeBosch, B. J. (2022) · Nature Communications · doi:10.1038/s41467-022-28717-7 · Cited by 43
NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging
Wagner, S., Manickam, R., Brotto, M. A. P., & Tipparaju, S. M. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04408-1 · Cited by 42
Matthews, E., & Dessent, C. E. H. (2016) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.6b10433 · Cited by 40
Brito, S., Baek, J.-M., Cha, B., Heo, H., Lee, S.-H., Lei, L., Jung, S. Y., Lee, S. M., Lee, S. H., Kwak, B.-M., et al. (2022) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2022.05.002 · Cited by 38
Anti-Aging Drugs and the Related Signal Pathways
Du, N., Ruigang, Y., Jiang, S., Niu, Z., Zhou, W., Liu, C., Gao, L., & Sun, Q. (2024) · Biomedicines · doi:10.3390/biomedicines12010127 · Cited by 43
Metabolic aspects of neuronal degeneration: From a NAD+ point of view
Sasaki, Y. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.07.001 · Cited by 39
Torrens‐Mas, M., Perelló-Reus, C. M., Navas-Enamorado, C., Ibargüen-González, L., Sánchez-Polo, A., Segura‐Sampedro, J. J., Masmiquel, L., Barceló, C., & González‐Freire, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910547 · Cited by 42
Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation
Zhu, X., Liu, H., Chen, L., Wu, C., Liu, X., Cang, Y., Jiang, B., Yang, X., & Fan, G. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.10.007 · Cited by 38
AMPK phosphorylates NAMPT to regulate NAD + homeostasis under ionizing radiation
Liao, X., Huang, X., Li, X., Qiu, X., Li, M., Liu, R. R., He, T., & Tang, Q. (2022) · Open Biology · doi:10.1098/rsob.220213 · Cited by 38
“In brief, 10 ng purified recombinant AMPK proteins were incubated with 100 ng NAMPT in 25 µl of kinase buffer (50 mM Tris–HCl, pH 7.5, 100 mM KCl, 5 mM MgCl2, 1 mM Na3VO4, 50 µM DTT, 5% glycerol and 50 µM ATP) at 25°C for 1 h. 10 µCi [γ-32P]ATP and boiled NAMPT protein were used in the reaction system if autoradiograp…”
BackgroundInfluentialAhmed, M., Riaz, U., Lv, H., Amjad, M., Ahmed, S., Ali, S., Ghani, M. U., Hua, G., & Yang, L. (2024) · Antioxidants · doi:10.3390/antiox14010039 · Cited by 44
“Two major pathways are involved in NMN synthesis: one involves nicotinamide (NAM) being converted by NAMPT, while the other uses nicotinamide riboside (NR), which is processed by NR kinases (NRKs) [41].”
Mitochondrial Aging in the CNS: Unravelling Implications for Neurological Health and Disease
Steffan, D., Pezzini, C., Esposito, M., & Franco‐Romero, A. (2025) · Biomolecules · doi:10.3390/biom15091252 · Cited by 40
“Similarly, the NAD+/NADH ratio reflects mitochondrial metabolic status and modulates various enzymatic reactions, influencing deacetylation processes mediated by sirtuins across multiple cellular compartments [138].”
How the glycosyltransferase OGT catalyzes amide bond cleavage
Janetzko, J., Trauger, S. A., Lazarus, M. B., & Walker, S. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2173 · Cited by 37
NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies
Lin, J. B., & Apte, R. S. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.06.002 · Cited by 39
“Studies in mouse models lacking various sirtuins have revealed that they play important roles in numerous cellular processes, including DNA damage, stress responses, metabolism, and aging (Verdin, 2015).”
A Method to Monitor the NAD+ Metabolome—From Mechanistic to Clinical Applications
Giner, M. P., Christen, S., Bártová, S., Makarov, M. V., Migaud, M. E., Cantó, C., & Moco, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910598 · Cited by 39
Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress
Xu, R., Yuan, Z., Yang, L., Li, L., Li, D., & Lv, C. (2017) · Oncology Reports · doi:10.3892/or.2017.5793 · Cited by 36
Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies
Djouadi, F., & Bastin, J. (2019) · Cells · doi:10.3390/cells8040289 · Cited by 37
Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation
Yang, B., & Shi, J. (2020) · Advanced Science · doi:10.1002/advs.202001388 · Cited by 38
Hu, Y. R., Xing, S. L., Chen, C., Shen, D. Z., & Chen, J. L. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210608103831 · Cited by 43
Ren, C., Hu, C., Wu, Y., Li, T., Zou, A., Yu, D., Shen, T., Cai, W., & Yu, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5961123 · Cited by 37
The Aged Intestine: Performance and Rejuvenation
Wang, Q., Qi, Y., Shen, W., Xu, J., Wang, L., Chen, S., Hou, T., & Si, J. (2021) · Aging and Disease · doi:10.14336/ad.2021.0202 · Cited by 40
Sasaki, L., Hamada, Y., Yarimizu, D., Suzuki, T., Nakamura, H., Shimada, A., Pham, K. T. N., Shao, X., Yamamura, K., Inatomi, T., et al. (2022) · Nature Aging · doi:10.1038/s43587-021-00167-8 · Cited by 37
Yao, L., Wu, Y., Zhuang, W., Zhao, H., Nie, W., Wu, G., Pang, D., & Xie, H.-Y. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01402-y · Cited by 42
French, S. W. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.02.004 · Cited by 36
“Nicotinamide mononucleotide (NMN) fed to mice with a high fat diet and type 2 diabetes restores NAD+ levels to normal and improves glucose tolerance and lipid profiles in older mice (Verdin 2015).”
BackgroundInfluentialDopamine Triggers CTCF-Dependent Morphological and Genomic Remodeling of Astrocytes
Galloway, A. L., Adeluyi, A., O’Donovan, B., Fisher, M. L., Rao, C. N., Critchfield, P., Sajish, M., Turner, J. R., & Ortinski, P. I. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3349-17.2018 · Cited by 41
“Furthermore, a number of studies have demonstrated that DA-induced increase in astrocytic Ca 2 impacts cellular respiration mechanisms coupled to PARP1 and sirtuin activation (Requardt et al., 2010, 2012; Verdin, 2015; Gupte et al., 2017).”
BackgroundMokarizadeh, N., Karimi, P., Erfani, M., Sadigh‐Eteghad, S., Maroufi, N. F., & Rashtchizadeh, N. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106300 · Cited by 36
Xu, W., Li, L., & Zhang, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00901 · Cited by 35
“The details have been recently reviewed elsewhere (Verdin, 2015; Matasic et al., 2018; Katsyuba et al., 2020).”
BackgroundPeclat, T., Shi, B., Varga, J., & Chini, E. N. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000737 · Cited by 34
Wang, J., Liu, L., Ding, Z. J., Luo, Q., Ju, Y., & Song, G. (2021) · Antioxidants · doi:10.3390/antiox10020254 · Cited by 36
“Nicotinamide adenine dinucleotide (NAD+) is a common coenzyme of multiple metabolic enzymes in all living cells [5].”
BackgroundAwad, H. H., El-Derany, M. O., Mantawy, E. M., Michel, H. E., El-Naa, M. M., Din, R. A. S. E., El-Brairy, A. I., & El‐Demerdash, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111679 · Cited by 35
Metabolic Control of Germline Formation and Differentiation in Mammals
Hayashi, Y., & Matsui, Y. (2022) · Sexual Development · doi:10.1159/000520662 · Cited by 43
“A Sitruin co-factor, NAD+, is synthesized mainly through the nicotinamide (NAM) salvage pathway and the NADH oxidation in the electron transport chain [Verdin, 2015].”
Li, T., Zou, Y., Liu, S., Yang, Y., Zhang, Z., & Zhao, Y. (2022) · Cell Regeneration · doi:10.1186/s13619-021-00105-4 · Cited by 37
“As NADH oxidized form, NAD+ is mainly synthesized through three pathways, including the salvage pathway from the precursor nicotinamide, nicotinamide mononucleotide, nicotinamide riboside or dihydronicotinamide riboside (Verdin 2015); the PreissHandler pathway from nicotinic acid (Verdin 2015); or the de novo pathway…”
BackgroundInfluentialLeung, C. K.-S., Ren, S. T., Chan, P. P. M., Wan, K. H.-N., Kam, A. K. W., Lai, G. W. K., Chiu, V. S. M., Ko, M. W. L., Yiu, K. F. C., & Yu, M. (2022) · Trials · doi:10.1186/s13063-021-05968-1 · Cited by 38
Zhang, S., Zhao, J., Quan, Z., Li, H., & Qing, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.853911 · Cited by 42
“NF-κB activation and decreased FOXO3a activity, which causes neural inflammation and cognitive dysfunction (Verdin, 2015).”
BackgroundChemical mitophagy modulators: Drug development strategies and novel regulatory mechanisms
Dong, Y. J., Zhuang, X., Wang, Y.-T., Tan, J., Feng, D., Li, M., Zhong, Q., Song, Z., Shen, H., Fang, E. F., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106835 · Cited by 39
Pyridine Dinucleotides from Molecules to Man
Fessel, J. P., & Oldham, W. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7120 · Cited by 38
Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging
Rahman, S. U., Qadeer, A., & Wu, Z. (2024) · Aging and disease · doi:10.14336/ad.2023.0519-1 · Cited by 34
“Although, ingestion of a high-fat diet (HFD) and aging cause a decrease in the level of NAD + [68].”
BackgroundZhang, J., Liu, Y., Zhi, X., Li, X., Tao, J., Cui, D., & Liu, T. F. (2024) · Inflammation Research · doi:10.1007/s00011-024-01878-5 · Cited by 37
“…in the cytoplasm and nucleus, the nuclear enzyme adenosine diphosphate (ADP)-ribose transferases (ARTs) and poly-ADP-ribosyl polymerases (PARPs), the ectoen-zyme cyclic ADP-ribose (cADPR) synthases (CD38 and CD157), and the sirtuin (SIRT) family of NAD + -dependent lysine deacetylases [82, 86, 87].”
Vitamin B3 in Health and Disease: Toward the Second Century of Discovery
Jacobson, M. K., & Jacobson, E. L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8588-3_1 · Cited by 35
The yin and yang faces of the mitochondrial deacetylase sirtuin 3 in age-related disorders
Gomes, P., Viana, S., Nunes, S., Rolo, A. P., Palmeira, C. M., & Reis, F. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100983 · Cited by 34
Shrishrimal, S., Chatterjee, A., Kosmacek, E. A., Davis, P. J., McDonald, J. T., & Oberley‐Deegan, R. E. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.03.014 · Cited by 39
Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder
Mahajan, V. R., Elvig, S. K., Vendruscolo, L. F., Koob, G. F., Darcey, V. L., King, M. T., Kranzler, H. R., Volkow, N. D., & Wiers, C. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.781668 · Cited by 36
“NAD decreases with age (143, 144) and lower NAD levels are associated with neurodegenerative and neuropsychiatric disorders including Alzheimer’s Disease and schizophrenia (145).”
BackgroundGautam, M., Günay, A., Chandel, N. S., & Özdinler, P. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-08068-5 · Cited by 37
The Role of Palmitoleic Acid in Regulating Hepatic Gluconeogenesis through SIRT3 in Obese Mice
Guo, X., Jiang, X., Chen, K., Liang, Q., Zhang, S., Zheng, J., Ma, X., Jiang, H., Wu, H., & Tong, Q. (2022) · Nutrients · doi:10.3390/nu14071482 · Cited by 37
“Sirtuin 3 (SIRT3) is one of the seven members of sirtuins (SIRT1-7) in mammals [10].”
BackgroundBakula, D., Aliper, A. M., Mamoshina, P., Petr, M. A., Teklu, A., Baur, J. A., Campisi, J., Ewald, C. Y., Georgievskaya, A., Gladyshev, V. N., et al. (2018) · Aging · doi:10.18632/aging.101646 · Cited by 34
“Modulating nicotinamide adenine dinucleotide (NAD) levels is a promising strategy to treat age-associated physiological decline [34,35].”
BackgroundAggarwal, S., Yadav, V., Maiwall, R., Rastogi, A., Pamecha, V., Bedi, O., Maras, J. S., Trehanpati, N., & Ramakrishna, G. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.078 · Cited by 34
Liu, X., Tang, M., He, T.-Y., Zhao, S., Li, H.-Z., Zhao, L., Guo, Y., & Wang, X.-L. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s400936 · Cited by 33
“32 The master transcription factor in the regulation of mitochondrial antioxidant and clearance systems, as well as its biogenesis, is PGC-1α.”
Cellular and Mitochondrial NAD Homeostasis in Health and Disease
Waddell, J., Khatoon, R., & Kristián, T. (2023) · Cells · doi:10.3390/cells12091329 · Cited by 34
Enhancing healthy aging with small molecules: A mitochondrial perspective
Qin, X., Li, H., Zhao, H., Fang, L., & Wang, X. (2024) · Medicinal Research Reviews · doi:10.1002/med.22034 · Cited by 37
“20 This observation has sparked significant interest in developing strategies to elevate NAD + concentrations in cells, thereby enhancing mitochondrial performance and potentially offsetting aging ‐ related effects.”
BackgroundZhao, Y., Zhang, Z., Zou, Y., & Yang, Y. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7226 · Cited by 34
Mitochondrial Metabolism and Aging in Yeast
Baccolo, G., Stamerra, G., Pellegrino-Coppola, D., Orlandi, I., & Vai, M. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.001 · Cited by 39
Facile chemoenzymatic synthesis of a novel stable mimic of NAD +
Dai, Z., Zhang, X., Nasertorabi, F., Cheng, Q., Pei, H., Louie, S. G., Stevens, R. C., & Zhang, Y. (2018) · Chemical Science · doi:10.1039/c8sc03899f · Cited by 34
Syntheses and chemical properties of β-nicotinamide riboside and its analogues and derivatives
Makarov, M. V., & Migaud, M. E. (2019) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.15.36 · Cited by 33
Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight
Hopp, A.-K., & Hottiger, M. O. (2021) · Cells · doi:10.3390/cells10030680 · Cited by 33
Ramanathan, C., Lackie, T., Williams, D. H., Simone, P. S., Zhang, Y., & Bloomer, R. J. (2022) · Nutrients · doi:10.3390/nu14020300 · Cited by 35
Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance
Kuo, C., & Liu, C. J.-L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111884 · Cited by 37
Ye, B., Pei, Y., Wang, L., Meng, D., Zhang, Y., Zou, S., Li, H., Liu, J., Xie, Z., Tian, C., et al. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30522 · Cited by 39
Tricarboxylic acid cycle metabolites: new players in macrophage
Yang, Y., Cui, B.-B., Li, J., Shan, J.-J., Xu, J., Zhang, C.-Y., Wei, X.-T., Zhu, R.-R., & Wang, J. (2024) · Inflammation Research · doi:10.1007/s00011-024-01853-0 · Cited by 36
“NAD+ is critical for the activation of several signaling pathways and several NAD+- dependent molecules have been characterized, including poly(ADP-ribose) polymerases (PARPs) and sirtuin dea-cetylases (SIRTs) [60, 61].”
Xing, S., Hu, Y., Huang, X., Shen, D., & Chen, C. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10782 · Cited by 40
“However, few studies to date have directly explored the potential therapeutic effect of targeting naMPT and nad+ biosynthesis, despite it being known that nad+ is the starting point of the majority of key metabolic pathways and therefore the key governor of cellular aging and age-related processes (14,15).”
Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication
Lauritzen, K. H., Olsen, M. B., Ahmed, M. S., Yang, K., Rinholm, J. E., Bergersen, L. H., Esbensen, Q. Y., Sverkeli, L. J., Ziegler, M., Attramadal, H., et al. (2021) · eLife · doi:10.7554/elife.59828 · Cited by 35
“NAD is found in all living cells, and serves as a crucial coenzyme for enzymes that fuel reduction-oxidation reactions, carrying electrons from one metabolic intermediate to another, and as a substrate for enzymes such as PARPs and sirtuins (Verdin, 2015).”
BackgroundKang, Y. H., Tucker, S. A., Quevedo, S. F., Inal, A., Korzenik, J. R., & Haigis, M. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273080 · Cited by 33
“UC patients display altered mitochondrial morphology in the intestine Defects in NAD metabolism have been implicated in mitochondrial dysfunction [16].”
BackgroundPerspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases
Han, B. R., Wang, M., Li, J., Chen, Q., Sun, N., Yang, X., & Zhang, Q. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115613 · Cited by 32
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
Touat, M., Sourisseau, T., Dorvault, N., Chabanon, R. M., Garrido, M., Morel, D., Krastev, D. B., Bigot, L., Adam, J., Frankum, J. R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci90277 · Cited by 32
“SIRT1 has previously been described as being able to regulate NAMPT levels (23).”
Goligorsky, M. S. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.01.016 · Cited by 33
Implications of NAD + boosters in translational medicine
Kang, B. E., Choi, J., Stein, S., & Ryu, D. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13334 · Cited by 34
Wei, F., Tuong, Z. K., Omer, M., Ngo, C., Asiatico, J. T., Kinzel, M., Pugazhendhi, A. S., Khaled, A. R., Ghosh, R. R., & Coathup, M. J. (2023) · Bone Research · doi:10.1038/s41413-023-00273-w · Cited by 33
“In metabolism, NAD acts as an electron-carrying cofactor for oxidation‒reduction reactions, and electron transfer is the main function of NAD.(37) As such, NAD/NADH is an important cellular redox pair, among others, and may regulate ROS generation and scavenging.”
BackgroundRoth‐Walter, F., Adcock, I. M., Benito‐Villalvilla, C., Bianchini, R., Bjermer, L. H., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguíluz‐Gracia, I., et al. (2023) · Allergy · doi:10.1111/all.15977 · Cited by 35
“31 Poly(ADP-ribosyl) transferase (PARP1) activity, that uses NAD + and detects DNA damage, increases and further impairs mitochondrial activity.”
BackgroundBody-wide multi-omic counteraction of aging with GLP-1R agonism
Huang, J., Kwok, A. J., Li, J. C. Y., Chiu, C. L. H., Ip, B. Y. M., Tung, L. Y., Chan, R. C. H., Chan, D. T.-M., Wang, Z., Zheng, X., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.014 · Cited by 37
Nicotinamide adenine dinucleotide replenishment rescues colon degeneration in aged mice
Zhu, X., Shen, W., Wang, Y., Jaiswal, A., Ju, Z., & Sheng, Q. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.17 · Cited by 31
Host NAD+ metabolism and infections: therapeutic implications
Singhal, A., & Cheng, C. Y. (2018) · International Immunology · doi:10.1093/intimm/dxy068 · Cited by 32
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
Rotllán, N., Camacho, M., Tondo, M., Diarte‐Añazco, E. M. G., Canyelles, M., Méndez‐Lara, K. A., Benítez, S., Alonso, N., Mauricio, D., Escolá‐Gil, J. C., et al. (2021) · Antioxidants · doi:10.3390/antiox10121939 · Cited by 34
Amirazodi, M., Mehrabi, A., Rajizadeh, M. A., Bejeshk, M. A., Esmaeilpour, K., Daryanoosh, F., & Gaeini, A. A. (2022) · PubMed Central · doi:10.22038/ijbms.2022.57780.12853 · Cited by 35
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity
Ugamraj, H. S., Dang, K. H., Ouisse, L., Buelow, B., Chini, E. N., Castello, G., Allison, J., Clarke, S., Davison, L. M., Buelow, R., et al. (2022) · mAbs · doi:10.1080/19420862.2022.2095949 · Cited by 32
“ability to cross the blood–brain barrier, and off-target binding to other NAD-dependent enzymes.(3,11,15,16) Daratumumab (Darzalex, Janssen Pharmaceuticals) and isatuximab (SARCLISA, Sanofi-Aventis) are potent antiCD38 antibodies developed for the depletion of malignant plasma cells.”
BackgroundRoles of microglial mitophagy in neurological disorders
Liu, Y., Wang, M., Hou, X., & Hu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.979869 · Cited by 36
“A growing number of studies have reported a decrease in intracellular NAD+ levels during aging and age-related diseases (Verdin, 2015).”
BackgroundNMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies
Loreto, A., Antoniou, C., Merlini, E., Gilley, J., & Coleman, M. P. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.01.004 · Cited by 35
“Preserving NAD homeostasis is, therefore, essential for life (Verdin 2015).”
Low-Dose Pesticide Mixture Induces Accelerated Mesenchymal Stem Cell Aging In Vitro
Lévêque, X., Hochane, M., Geraldo, F., Dumont, S., Gratas, C., Oliver, L., Gaignier, C., Trichet, V., Layrolle, P., Heymann, D., et al. (2019) · Stem Cells · doi:10.1002/stem.3014 · Cited by 32
NMR Metabolomics Protocols for Drug Discovery
Bhinderwala, F., & Powers, R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9690-2_16 · Cited by 31
Imai, S. (2025) · npj Aging · doi:10.1038/s41514-025-00192-6 · Cited by 31
SLC29A1 and SLC29A2 are human nicotinamide cell membrane transporters
Chen, M., Yuan, L., Chen, B., Chang, H., Luo, J., Zhang, H., Chen, Z., Kong, J., Yi, Y., Bai, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56402-y · Cited by 30
Mechanotransduction for therapeutic approaches: Cellular aging and rejuvenation
Han, H.-M., Kim, S.-Y., & Kim, D. (2025) · APL Bioengineering · doi:10.1063/5.0263236 · Cited by 39
“78,79 When NAD þ levels decline, sirtuin1 activity decreases, leading to senescence through the p53 and p16INK4a pathways.”
Kim, J., Ko, S., Noh, C., Kim, H., Lee, S., Kim, D., Park, H., Kwon, G., Son, G., Ko, J. W., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201906844 · Cited by 30
Therapeutic potential of nicotinamide adenine dinucleotide (NAD)
Arenas‐Jal, M., Suñé-Negre, J. M., & García‐Montoya, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173158 · Cited by 36
Metabolic syndrome exacerbates amyloid pathology in a comorbid Alzheimer's mouse model
Tyagi, A., Mirita, C., Taher, N., Shah, I., Moeller, E., Tyagi, A., Chong, T., & Pugazhenthi, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165849 · Cited by 31
Yang, T., Wang, Y., Liao, W., Zhang, S., Wang, S., Xu, N., Xie, W., Luo, C., Wang, Y., Wang, Z., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00705-2 · Cited by 32
“Therefore, the decline of NAD+ during aging influences many key cellular functions and induces many aging-associated diseases, including neurodegenerative diseases [16, 18].”
BackgroundMetabolomics in aging research: aging markers from organs
Fang, W., Chen, S., Jin, X., Liu, S., Cao, X., & Liu, B. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1198794 · Cited by 33
“…mentioned that its levels decrease during aging (Mitchell et al., 2000; Rebrin and Sohal, 2008; Cantor and Sabatini, 2012; Homma and Fujii, 2015; Verdin, 2015; DeBerardinis and Chandel, 2016; Pavlova and Thompson, 2016), which is consistent with the results of metabolomic studies in recent…”
ResultWeidele, K., Beneke, S., & Bürkle, A. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.02.001 · Cited by 33
SIRT2 reduces actin polymerization and cell migration through deacetylation and degradation of HSP90
Min, J. S., Kim, J. C., Kim, J. A., Kang, I., & Ahn, J. K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.06.005 · Cited by 31
Kynurenic Acid Plays a Protective Role in Hepatotoxicity Induced by HFPO-DA in Male Mice
Hu, J., Dai, J., & Sheng, N. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.3c08033 · Cited by 29
Giuffrè, M., Merli, N., Pugliatti, M., & Moretti, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063337 · Cited by 32
Kanamori, K. S., de Oliveira, G. C., Auxiliadora‐Martins, M., Schoon, R. A., Reid, J. M., & Chini, E. N. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2937 · Cited by 33
“In addition, it serves as a substrate for several enzymes involved in DNA damage repair, such as the sirtuins and poly (ADP-ribose) polymerases (PARPs) (Imai and Guarente, 2014; Verdin, 2015; Yoshino et al., 2018).”
BackgroundTargeting NAD+ Metabolism to Enhance Radiation Therapy Responses
Lewis, J. E., Singh, N., Holmila, R. J., Sumer, B. D., Williams, N. S., Furdui, C. M., Kemp, M. L., & Boothman, D. A. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.009 · Cited by 30
Culprit or Bystander: Defective Mitophagy in Alzheimer’s Disease
Xie, C., Aman, Y., Adriaanse, B. A., Cader, M. Z., Plun‐Favreau, H., Xiao, J., & Fang, E. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00391 · Cited by 29
“NAD+ is a fundamental molecule in human health and life since it participates in glycolysis, TCA cycle, OXPHOS, β-oxidation, and many other bioenergetic and metabolic pathways (Verdin, 2015; Fang et al., 2017a; Aman et al., 2018; Mitchell et al., 2018).”
BackgroundAcute sources of mitochondrial NAD+ during respiratory chain dysfunction
Chinopoulos, C. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113218 · Cited by 29
Metabolic regulation of immune cells in proinflammatory microenvironments and diseases during ageing
Li, P., Zhang, R., Cheng, L., Liu, J., & Chen, H. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101165 · Cited by 33
Nicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in Humans
Nascimento, E. B. M., Moonen, M. P. B., Remie, C. M. E., Gariani, K., Jörgensen, J. A., Schaart, G., Hoeks, J., Auwerx, J. H., Lichtenbelt, W. D. V. M., & Schrauwen, P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa960 · Cited by 30
NAD+ Homeostasis in Diabetic Kidney Disease
Xu, J., Kitada, M., & Koya, D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.703076 · Cited by 33
Li, H., Liu, F., Jiang, W., Wang, K., Cao, X., Zou, J., Zhou, Y., Li, Z., Liu, S., Cui, X., et al. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00459-2 · Cited by 31
“Therefore, boosting NAD+ expression contributes to SIRT3 activation (Eric 2015).”
BackgroundOdoh, C. K., Guo, X., Arnone, J. T., Wang, X., & Zhao, Z. K. (2022) · Biogerontology · doi:10.1007/s10522-022-09958-x · Cited by 30
“As a vital molecule in biological systems, diseases such as cancer, neuron degeneration and diabetes are linked to aberrant NAD metabolism (Canto et al. 2015; Nikiforov et al. 2015; Verdin 2015; Chini et al. 2017).”
BackgroundNAD+-boosting molecules suppress mast cell degranulation and anaphylactic responses in mice
Kim, H.-W., Ryoo, G.-H., Jang, H., Rah, S., Lee, D. H., Kim, D., Bae, E. J., & Park, B. (2022) · Theranostics · doi:10.7150/thno.69684 · Cited by 27
“Systemic or cellular NAD+ levels decline with age in humans as well as in rodents [7, 18].”
BackgroundLu, Z., Jiang, L., Lesani, P., Zhang, W., Li, N., Luo, D., Li, Y., Ye, Y., Bian, J., Wang, G., et al. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac175 · Cited by 33
Metadata
- Authors
- Verdin, E.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Verdin, Eric
- ORCID
- Verdin, Eric
- Venue
- Science
- Published
- 2015-12-04
- Volume
- 350
- Issue
- 6265
- Pages
- 1208-1213
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2284984697
- Cited by
- 1,319
- References
- 116
- Citations by year
- 2026: 177 · 2025: 149 · 2024: 137 · 2023: 120 · 2022: 129 · 2021: 171 · 2020: 123 · 2019: 112 · 2018: 89 · 2017: 70 · 2016: 40 · 2015: 1
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK085610)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- NAD+, aging, metabolism, neurodegeneration, sirtuins, poly(ADP-ribose) polymerase, NAD+ precursors, NAD+ supplementation, healthspan, lifespan, redox reactions, coenzymes
- MeSH terms
- Aging, Diabetes Mellitus, Type 2, DNA Damage, Fatty Liver, Humans, Mitochondria, NAD, Obesity, Oxidation-Reduction, Poly(ADP-ribose) Polymerases, Neurodegenerative Diseases, Sirtuins, Biosynthetic Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.